How have VIVXF shares performed in 2024?

Avivagen's stock was trading at $0.0006 at the beginning of 2024. Since then, VIVXF shares have increased by 966.7% and is now trading at $0.0064. View the best growth stocks for 2024 here .

When is Avivagen's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, June 4th 2024. View our VIVXF earnings forecast .

How do I buy shares of Avivagen?

Shares of VIVXF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

OTCMKTS:VIVXF

Avivagen (VIVXF) Stock Price, News & Analysis

→ Biden’s $374B Giveaway Into This Sector (From DTI) (Ad)

Free VIVXF Stock Alerts

$0.0064

0.00 (0.00%)

(As of 04/19/2024 ET)

Compare

Today's Range: $0.0064
▼
$0.0064
50-Day Range: N/A
52-Week Range: $0.00
▼
$0.02

Volume: N/A
Average Volume: 540 shs
Market Capitalization: $497,216.00

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis Chart Earnings Short Interest

Get Avivagen alerts:

Ad DTI

Biden’s $374B Giveaway Into This Sector

Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here

Click here for the full story

About Avivagen Stock (OTCMKTS:VIVXF)

Avivagen Inc. focuses on developing and commercializing products for livestock feeds that support immune function and help animals to achieve their growth and productivity. The company offers OxC-beta Livestock, a premix for inclusion in livestock feeds; Vivamune health chews for dogs; Dr. Tobias dog chews; and Dr. Tobias Beta blend for the human immune system. It serves in Canada, Mexico, Brazil, the Philippines, Taiwan, and Thailand. Avivagen Inc. was incorporated in 2005 and is headquartered in Ottawa, Canada.

VIVXF Stock Price History

30 days | 90 days | 365 days | Advanced Chart

VIVXF Stock News Headlines

March 16, 2023 | businesswire.com

Avivagen Inc. Announces Results for the First Quarter Ending January 31, 2023

May 30, 2022 | financialpost.com

Avivagen Signs New Distribution Partner in Vietnam to Support Southeast Asian Growth

April 20, 2024 | Crypto 101 Media (Ad)

SHOCKING Crypto Leak…

A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024.

March 22, 2022 | financialpost.com

Avivagen to Attend CEM Sponsored Alpha North Conference

See More Headlines

Receive VIVXF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Avivagen and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today: 4/20/2024
Next Earnings (Estimated): 6/04/2024
Fiscal Year End: 10/31/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: OTCMKTS
Sector: Medical
Industry: Private households
Sub-Industry: N/A
Current Symbol: OTCMKTS:VIVXF
CUSIP: N/A
CIK: N/A
Web: www.avivagen.com
Phone: 613-702-2908
Fax: N/A
Employees: 13
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): ($0.04)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-4,710,000.00
Net Margins: -645.05%
Pretax Margin: -645.42%
Return on Equity: N/A
Return on Assets: -716.72%

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 0.03
Quick Ratio: 0.02

Sales & Book Value

Annual Sales: $730,000.00
Price / Sales: 0.68
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: ($0.06) per share
Price / Book: -0.11

Miscellaneous

Outstanding Shares: 77,690,000
Free Float: 76,063,000
Market Cap: $497,216.00
Optionable: Not Optionable
Beta: 0.12

12 Stocks Corporate Insiders are Abandoning

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?

Get This Free Report

Key Executives

Mr. G. F. Kym Anthony (Age 68)
CEO & Vice Chairman
Comp: $265.84k
Dr. Graham Burton Ph.D.
Co-Founder, Chief Scientific Officer & Director
Mr. Ira Levy
Interim Chief Financial Officer
Dr. James Nickerson Ph.D.
President and Executive VP of Business Development & Product Innovation
Mr. Drew Basek
Director of Investor Relations
Ms. Tracy Gillett BVSC
Director of Companion Animal & Marketing Manager

Key Competitors

View All Competitors

VIVXF Stock Analysis - Frequently Asked Questions

How have VIVXF shares performed in 2024?: Avivagen's stock was trading at $0.0006 at the beginning of 2024. Since then, VIVXF shares have increased by 966.7% and is now trading at $0.0064.
View the best growth stocks for 2024 here.
When is Avivagen's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Tuesday, June 4th 2024.
View our VIVXF earnings forecast.
How do I buy shares of Avivagen?: Shares of VIVXF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:VIVXF) was last updated on 4/20/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial